Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Collins

Showing results (311-320 of 428) with videos related to

Pageof 43
Sort By:
BMC Nephrology|February 6, 2021
Effect of balanced crystalloids versus saline on urinary biomarkers of acute kidney injury in critically ill adultsBlake E Funke, Karen E Jackson, Wesley H Self, et al.
Journal of the American College of Cardiology|April 3, 2024
Efficacy and Safety of Dapagliflozin in Patients With Acute Heart FailureZachary L Cox, Sean P Collins, Gabriel A Hernandez, et al.
European Heart Journal|November 13, 2009
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea studyAlexandre Mebazaa, Peter S Pang, Miguel Tavares, et al.
Heart Failure Reviews|August 30, 2025
Infective endocarditis complicated by shock: a systematic review and meta-analysisRoxana-Bianca Pîrîianu-Masgras, Alexandre Mebazaa, Gianluigi Savarese, et al.
European Heart Journal|May 2, 2017
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)Peter S Pang, Javed Butler, Sean P Collins, et al.
Intensive Care Medicine|February 20, 2020
Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists WorkshopMichael O Harhay, Jonathan D Casey, Marina Clement, et al.
JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.
Journal of Cardiac Failure|August 1, 2009
The rationale for an acute heart failure syndromes clinical trials networkSean P Collins, Phillip D Levy, Christopher J Lindsell, et al.
European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.
Frontiers in Oncology|February 4, 2021
Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation TherapyMichael Carrasquilla, Michael L Creswell, Abigail N Pepin, et al.
Pageof 43

Showing results (311-320 of 428) with videos related to

Sort By:
Pageof 43
BMC Nephrology|February 6, 2021
Effect of balanced crystalloids versus saline on urinary biomarkers of acute kidney injury in critically ill adultsBlake E Funke, Karen E Jackson, Wesley H Self, et al.
Journal of the American College of Cardiology|April 3, 2024
Efficacy and Safety of Dapagliflozin in Patients With Acute Heart FailureZachary L Cox, Sean P Collins, Gabriel A Hernandez, et al.
European Heart Journal|November 13, 2009
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea studyAlexandre Mebazaa, Peter S Pang, Miguel Tavares, et al.
Heart Failure Reviews|August 30, 2025
Infective endocarditis complicated by shock: a systematic review and meta-analysisRoxana-Bianca Pîrîianu-Masgras, Alexandre Mebazaa, Gianluigi Savarese, et al.
European Heart Journal|May 2, 2017
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)Peter S Pang, Javed Butler, Sean P Collins, et al.
Intensive Care Medicine|February 20, 2020
Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists WorkshopMichael O Harhay, Jonathan D Casey, Marina Clement, et al.
JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.
Journal of Cardiac Failure|August 1, 2009
The rationale for an acute heart failure syndromes clinical trials networkSean P Collins, Phillip D Levy, Christopher J Lindsell, et al.
European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.
Frontiers in Oncology|February 4, 2021
Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation TherapyMichael Carrasquilla, Michael L Creswell, Abigail N Pepin, et al.
Pageof 43